newsfilter
← Latest News
GlobeNewswire·

Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates

  • Investor interest in peptide-based health products is rising as the global peptide therapeutics market is projected to grow from $117 billion in 2024 to over $260 billion by 2030.
  • The Precision Peptide Company Inc. (OTCQB: PNGAF) announced an exclusive strategic marketing partnership with Mixed Martial Arts Group Limited effective May 8, 2026.
  • MMA will market the company's US-manufactured peptide products to its subscriber base of over 5 million social media followers, 530,000 user profiles, 75,000 active students, and 800 verified gyms.
  • Under the agreement, net revenue from MMA-sourced sales is split 50/50 for the first 12 months, then shifts to 75% for the company and 25% for MMA thereafter.
  • The partnership agreement allows termination by either party with 30 days' written notice, with revenue sharing continuing for 12 months post-termination for referred customers.
  • Pfizer Inc. reported positive Phase 2b VESPER-3 study results for its injectable GLP-1 receptor agonist PF'3944, showing efficacy in monthly dosing for weight management.
  • Amazon Pharmacy is expanding access to Novo Nordisk A/S's oral GLP-1 medication Ozempic pill with same-day delivery options starting at $25 per month with insurance.
  • Hims & Hers Health Inc. reported Q1 2026 financial results, noting a strategic pivot to branded GLP-1 products and targeting $6.5 billion in revenue by 2030.
  • Eli Lilly and Company announced a $4.5 billion expansion of its Lebanon, Indiana sites, bringing total capital commitments since 2020 to over $21 billion.
  • Lilly's Lebanon Advanced Therapies facility will support the clinical and commercial production of genetic medicines using new manufacturing processes.
  • The article identifies The Precision Peptide Company, Pfizer, Novo Nordisk, Hims & Hers, and Eli Lilly as key companies advancing in the peptide wellness sector.
  • A disclaimer states that Market News Updates is not affiliated with the mentioned companies, holds no shares, and provides no investment advice.